Oncology Institute Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2.3% | +4.6% | +10.3% | +4.1% | +1.3% | +0.4% | +4.1% | +14.7% | +14.0% | +3.9% | +3.9% | – | |
| – | +1.5% | +8.1% | +15.8% | +3.5% | 0.0% | +0.1% | +1.8% | +17.4% | +15.0% | +1.3% | +5.5% | – | |
| – | +5.7% | -10.0% | -16.8% | +8.8% | +10.3% | +1.9% | +17.9% | +1.5% | +8.1% | +20.3% | -4.7% | – | |
| – | -1.8% | -0.4% | +1.3% | -2.0% | -4.4% | -6.7% | +2.1% | +6.0% | -6.2% | +11.0% | +0.6% | – | |
| – | -0.5% | -0.8% | +0.9% | -1.8% | -4.0% | -5.9% | +2.2% | +5.7% | -6.1% | +10.0% | -4.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.9% | -28.0% | +2.3% | +6.7% | +5.1% | -47.5% | +376.9% | -66.4% | +2.7% | -0.2% | +0.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +36.4% | -332.6% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.